110 related articles for article (PubMed ID: 2336196)
21. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
Kilpatrick GJ; Jones BJ; Tyers MB
Nature; 1987 Dec 24-31; 330(6150):746-8. PubMed ID: 3696238
[TBL] [Abstract][Full Text] [Related]
22. Effects of detergents on binding of 5-hydroxytryptamine3 receptor antagonist [3H]GR65630 to rat cortical membranes.
Inoue A; Tominaga Y; Nishio H; Segawa T; Nakata Y
Neurochem Int; 1993 Jun; 22(6):547-53. PubMed ID: 8513282
[TBL] [Abstract][Full Text] [Related]
23. The subnuclear distribution of 5-HT3 receptors in the human nucleus of the solitary tract and other structures of the caudal medulla.
Ohuoha DC; Knable MB; Wolf SS; Kleinman JE; Hyde TM
Brain Res; 1994 Feb; 637(1-2):222-6. PubMed ID: 8180799
[TBL] [Abstract][Full Text] [Related]
24. [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.
Hoyer D; Waeber C; Karpf A; Neijt H; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):396-402. PubMed ID: 2586633
[TBL] [Abstract][Full Text] [Related]
25. Ethanol fails to modify [3H]GR65630 binding to 5-HT3 receptors in NCB-20 cells and in rat cerebral membranes.
Hellevuo K; Hoffman PL; Tabakoff B
Alcohol Clin Exp Res; 1991 Oct; 15(5):775-8. PubMed ID: 1755508
[TBL] [Abstract][Full Text] [Related]
26. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY
Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139
[TBL] [Abstract][Full Text] [Related]
27. 5-hydroxytryptamine3 receptors in the human brain: autoradiographic visualization using [3H]ICS 205-930.
Waeber C; Hoyer D; Palacios JM
Neuroscience; 1989; 31(2):393-400. PubMed ID: 2797443
[TBL] [Abstract][Full Text] [Related]
28. 5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide.
Boess FG; Sepúlveda MI; Lummis SC; Martin IL
Neuropharmacology; 1992 Jun; 31(6):561-4. PubMed ID: 1407396
[TBL] [Abstract][Full Text] [Related]
29. Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cells.
Lummis SC; Kilpatrick GJ; Martin IL
Eur J Pharmacol; 1990 Sep; 189(2-3):223-7. PubMed ID: 2253704
[TBL] [Abstract][Full Text] [Related]
30. [3H] GR67330, a very high affinity ligand for 5-HT3 receptors.
Kilpatrick GJ; Butler A; Hagan RM; Jones BJ; Tyers MB
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):22-30. PubMed ID: 2402301
[TBL] [Abstract][Full Text] [Related]
31. Evidence for presynaptic 5-hydroxytryptamine3 recognition sites on vagal afferent terminals in the brainstem of the ferret.
Leslie RA; Reynolds DJ; Andrews PL; Grahame-Smith DG; Davis CJ; Harvey JM
Neuroscience; 1990; 38(3):667-73. PubMed ID: 2176720
[TBL] [Abstract][Full Text] [Related]
32. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.
Steward LJ; Ge J; Bentley KR; Barber PC; Hope AG; Lambert JJ; Peters JA; Blackburn TP; Barnes NM
Br J Pharmacol; 1995 Sep; 116(2):1781-8. PubMed ID: 8528560
[TBL] [Abstract][Full Text] [Related]
33. [3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.
Gordon JC; Barefoot DS; Sarbin NS; Pinkus LM
J Pharmacol Exp Ther; 1989 Dec; 251(3):962-8. PubMed ID: 2600824
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
[TBL] [Abstract][Full Text] [Related]
35. The 5-HT3 receptor ligand, [3H]BRL 43694, binds to presynaptic sites in the nucleus tractus solitarius of the rat.
Pratt GD; Bowery NG
Neuropharmacology; 1989 Dec; 28(12):1367-76. PubMed ID: 2559349
[TBL] [Abstract][Full Text] [Related]
36. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.
Pazos A; Palacios JM
Brain Res; 1985 Nov; 346(2):205-30. PubMed ID: 4052776
[TBL] [Abstract][Full Text] [Related]
37. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.
Eglen RM; Swank SR; Walsh LK; Whiting RL
Br J Pharmacol; 1990 Nov; 101(3):513-20. PubMed ID: 2076474
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the novel 5-HT3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma x glioma cells.
Boeijinga PH; Galvan M; Baron BM; Dudley MW; Siegel BW; Slone AL
Eur J Pharmacol; 1992 Aug; 219(1):9-13. PubMed ID: 1397053
[TBL] [Abstract][Full Text] [Related]
39. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
Barnes JM; Barnes NM
Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
[TBL] [Abstract][Full Text] [Related]
40. Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor.
Wetzel CH; Hermann B; Behl C; Pestel E; Rammes G; Zieglgänsberger W; Holsboer F; Rupprecht R
Mol Endocrinol; 1998 Sep; 12(9):1441-51. PubMed ID: 9731711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
